Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 361

1.

Sustained remission with etanercept tapering in early rheumatoid arthritis.

Emery P, Hammoudeh M, FitzGerald O, Combe B, Martin-Mola E, Buch MH, Krogulec M, Williams T, Gaylord S, Pedersen R, Bukowski J, Vlahos B.

N Engl J Med. 2014 Nov 6;371(19):1781-92. doi: 10.1056/NEJMoa1316133.

PMID:
25372086
[PubMed - indexed for MEDLINE]
2.

Drug therapies for peripheral joint disease in psoriatic arthritis: a systematic review.

Acosta Felquer ML, Coates LC, Soriano ER, Ranza R, Espinoza LR, Helliwell PS, FitzGerald O, McHugh N, Roussou E, Mease PJ.

J Rheumatol. 2014 Nov;41(11):2277-85. doi: 10.3899/jrheum.140876.

PMID:
25362711
[PubMed - in process]
3.

Certain class I HLA alleles and haplotypes implicated in susceptibility play a role in determining specific features of the psoriatic arthritis phenotype.

Haroon M, Winchester R, Giles JT, Heffernan E, FitzGerald O.

Ann Rheum Dis. 2014 Sep 26. pii: annrheumdis-2014-205461. doi: 10.1136/annrheumdis-2014-205461. [Epub ahead of print]

PMID:
25261574
[PubMed - as supplied by publisher]
4.

Profound reduction in hospital admissions and musculoskeletal surgical procedures for rheumatoid arthritis with concurrent changes in clinical practice (1995-2010).

Harty L, O'Toole G, FitzGerald O.

Rheumatology (Oxford). 2014 Sep 22. pii: keu340. [Epub ahead of print]

PMID:
25246639
[PubMed - as supplied by publisher]
5.

Discovery and confirmation of a protein biomarker panel with potential to predict response to biological therapy in psoriatic arthritis.

Ademowo OS, Hernandez B, Collins E, Rooney C, Fearon U, van Kuijk AW, Tak PP, Gerlag DM, FitzGerald O, Pennington SR.

Ann Rheum Dis. 2014 Sep 3. pii: annrheumdis-2014-205417. doi: 10.1136/annrheumdis-2014-205417. [Epub ahead of print]

PMID:
25187158
[PubMed - as supplied by publisher]
6.

Qualifying unmet needs and improving standards of care in psoriatic arthritis.

Helliwell P, Coates L, Chandran V, Gladman D, de Wit M, FitzGerald O, Kavanaugh A, Strand V, Mease PJ, Boehncke WH, Langley RG, Lubrano E, Maccarone M, Schulze-Koops H, Miceli-Richard C, Queiro R.

Arthritis Care Res (Hoboken). 2014 Dec;66(12):1759-66. doi: 10.1002/acr.22404. No abstract available.

PMID:
25047391
[PubMed - in process]
Free Article
7.

How much is fatigue explained by standard clinical characteristics of disease activity in patients with inflammatory arthritis? A longitudinal study.

Minnock P, McKee G, Bresnihan B, FitzGerald O, Veale DJ.

Arthritis Care Res (Hoboken). 2014 Nov;66(11):1597-603. doi: 10.1002/acr.22387.

PMID:
24966144
[PubMed - in process]
8.

High prevalence of metabolic syndrome and of insulin resistance in psoriatic arthritis is associated with the severity of underlying disease.

Haroon M, Gallagher P, Heffernan E, FitzGerald O.

J Rheumatol. 2014 Jul;41(7):1357-65. doi: 10.3899/jrheum.140021. Epub 2014 Jun 15.

PMID:
24931949
[PubMed - in process]
9.

A novel evidence-based detection of undiagnosed spondyloarthritis in patients presenting with acute anterior uveitis: the DUET (Dublin Uveitis Evaluation Tool).

Haroon M, O'Rourke M, Ramasamy P, Murphy CC, FitzGerald O.

Ann Rheum Dis. 2014 Jun 13. pii: annrheumdis-2014-205358. doi: 10.1136/annrheumdis-2014-205358. [Epub ahead of print]

PMID:
24928841
[PubMed - as supplied by publisher]
10.

GRAPPA 2013 Annual Meeting, rheumatology updates: psoriatic arthritis (PsA) biomarker project, arthritis mutilans, PsA-peripheral spondyloarthritis epidemiology project.

FitzGerald O, Mease PJ, Helliwell PS, Chandran V.

J Rheumatol. 2014 Jun;41(6):1244-8. doi: 10.3899/jrheum.140181.

PMID:
24882863
[PubMed - in process]
11.

Composite disease activity and responder indices for psoriatic arthritis: a report from the GRAPPA 2013 meeting on development of cutoffs for both disease activity states and response.

Helliwell PS, FitzGerald O, Fransen J.

J Rheumatol. 2014 Jun;41(6):1212-7. doi: 10.3899/jrheum.140172.

PMID:
24882854
[PubMed - in process]
12.

Patient participation in psoriasis and psoriatic arthritis outcome research: a report from the GRAPPA 2013 Annual Meeting.

de Wit M, Campbell W, FitzGerald O, Gladman DD, Helliwell PS, James J, Lindsay C, MacDonald R, McHugh NJ, Mease PJ, Orbai AM, Palominos P, Parkinson A, Tillett W, Goel N.

J Rheumatol. 2014 Jun;41(6):1206-11. doi: 10.3899/jrheum.140171.

PMID:
24882853
[PubMed - in process]
13.

Spondyloarthropathies: Apremilast: welcome advance in treatment of psoriatic arthritis.

FitzGerald O.

Nat Rev Rheumatol. 2014 Jul;10(7):385-6. doi: 10.1038/nrrheum.2014.77. Epub 2014 May 20. No abstract available.

PMID:
24846499
[PubMed - indexed for MEDLINE]
14.

Patient involvement in outcome measures for psoriatic arthritis.

Tillett W, Adebajo A, Brooke M, Campbell W, Coates LC, FitzGerald O, Gossec L, Helliwell P, Hewlett S, James J, Minnock P, Reast A, O'Sullivan D, de Wit M, McHugh N.

Curr Rheumatol Rep. 2014 May;16(5):418. doi: 10.1007/s11926-014-0418-7. Review.

PMID:
24623563
[PubMed - indexed for MEDLINE]
15.

Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis.

Haroon M, Gallagher P, Fitzgerald O.

Ann Rheum Dis. 2014 Feb 27. doi: 10.1136/annrheumdis-2013-204858. [Epub ahead of print]

PMID:
24525911
[PubMed - as supplied by publisher]
16.

Development of a disease activity and responder index for psoriatic arthritis--report of the Psoriatic Arthritis Module at OMERACT 11.

Coates LC, FitzGerald O, Mease PJ, Gladman DD, Strand V, Goel N, Campbell I, Krueger G, McHugh NJ, Helliwell PS.

J Rheumatol. 2014 Apr;41(4):782-91. doi: 10.3899/jrheum.131250. Epub 2014 Feb 1. Review.

PMID:
24488420
[PubMed - indexed for MEDLINE]
17.

Development and testing of new candidate psoriatic arthritis screening questionnaires combining optimal questions from existing tools.

Coates LC, Walsh J, Haroon M, FitzGerald O, Aslam T, Al Balushi F, Burden AD, Burden-Teh E, Caperon AR, Cerio R, Chattopadhyay C, Chinoy H, Goodfield MJ, Kay L, Kelly S, Kirkham BW, Lovell CR, Marzo-Ortega H, McHugh N, Murphy R, Reynolds NJ, Smith CH, Stewart EJ, Warren RB, Waxman R, Wilson HE, Helliwell PS.

Arthritis Care Res (Hoboken). 2014 Sep;66(9):1410-6. doi: 10.1002/acr.22284.

PMID:
24470406
[PubMed - indexed for MEDLINE]
18.

Editorial: emerging evidence for critical involvement of the interleukin-17 pathway in both psoriasis and psoriatic arthritis.

Fitzgerald O, Winchester R.

Arthritis Rheumatol. 2014 May;66(5):1077-80. doi: 10.1002/art.38370. No abstract available.

PMID:
24470140
[PubMed - indexed for MEDLINE]
19.

Comparison of remission criteria in a tumour necrosis factor inhibitor treated rheumatoid arthritis longitudinal cohort: patient global health is a confounder.

Balogh E, Madruga Dias J, Orr C, Mullan R, Harty L, FitzGerald O, Gallagher P, Molloy M, O'Flynn E, Kelly A, Minnock P, O'Neill M, Moore L, Murray M, Fearon U, Veale DJ.

Arthritis Res Ther. 2013 Dec 24;15(6):R221. doi: 10.1186/ar4421.

PMID:
24365061
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Th17 and Th22 cells in psoriatic arthritis and psoriasis.

Benham H, Norris P, Goodall J, Wechalekar MD, FitzGerald O, Szentpetery A, Smith M, Thomas R, Gaston H.

Arthritis Res Ther. 2013 Sep 26;15(5):R136. doi: 10.1186/ar4317.

PMID:
24286492
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk